BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37206723)

  • 1. Biologic Therapies in Chronic Rhinosinusitis with Nasal Polyposis: Overview of Systematic Reviews and Updated Systematic Review.
    Mirza AA; Abdulazeem HM; Al-Sayed AA; Alandejani TA; Shawli HY; Thompson JY; Alhaddad MH; Varshney R; Zawawi F
    Indian J Otolaryngol Head Neck Surg; 2023 Apr; 75(Suppl 1):650-660. PubMed ID: 37206723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biologic Therapies for Allergic Rhinitis and Nasal Polyposis.
    Geng B; Dilley M; Anterasian C
    Curr Allergy Asthma Rep; 2021 Jun; 21(6):36. PubMed ID: 34110505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Thomas K; Guiang H
    Curr Med Res Opin; 2020 Nov; 36(11):1897-1911. PubMed ID: 32847417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is generative pre-trained transformer artificial intelligence (Chat-GPT) a reliable tool for guidelines synthesis? A preliminary evaluation for biologic CRSwNP therapy.
    Maniaci A; Saibene AM; Calvo-Henriquez C; Vaira L; Radulesco T; Michel J; Chiesa-Estomba C; Sowerby L; Lobo Duro D; Mayo-Yanez M; Maza-Solano J; Lechien JR; La Mantia I; Cocuzza S
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):2167-2173. PubMed ID: 38329526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-IgE and Anti-IL5 Biologic Therapy in the Treatment of Nasal Polyposis: A Systematic Review and Meta-analysis.
    Rivero A; Liang J
    Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):739-747. PubMed ID: 28918644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics for chronic rhinosinusitis.
    Chong LY; Piromchai P; Sharp S; Snidvongs K; Webster KE; Philpott C; Hopkins C; Burton MJ
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013513. PubMed ID: 33710614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic literature review of humanistic and economic burdens of chronic rhinosinusitis with nasal polyposis.
    Chen S; Zhou A; Emmanuel B; Garcia D; Rosta E
    Curr Med Res Opin; 2020 Nov; 36(11):1913-1926. PubMed ID: 32851882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP.
    Bachert C; Zinreich SJ; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Amin N; Joish VN; Fan C; Zhang D; Staudinger H; Pirozzi G; Graham NMH; Khan A; Mannent LP
    Rhinology; 2020 Feb; 58(1):10-17. PubMed ID: 31671432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
    Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The argument against the use of dupilumab in patients with limited polyp burden in chronic rhinosinusitis with nasal polyposis (CRSwNP).
    Hardison SA; Senior BA
    J Otolaryngol Head Neck Surg; 2023 Sep; 52(1):64. PubMed ID: 37759322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of manual therapy for knee osteoarthritis: An overview of systematic reviews and meta-analyses.
    Feng T; Wang X; Jin Z; Qin X; Sun C; Qi B; Zhang Y; Zhu L; Wei X
    Front Public Health; 2023; 11():1081238. PubMed ID: 36908468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of omalizumab in the treatment of chronic rhinosinusitis with nasal polyposis.
    Aldinger JP; Dobyns T; Lam K; Han JK
    Expert Opin Biol Ther; 2021 Sep; 21(9):1143-1149. PubMed ID: 34334061
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness and safety of acupuncture for treating functional constipation: An overview of systematic reviews.
    Yao JP; Chen LP; Xiao XJ; Hou TH; Zhou SY; Xu MM; Wang K; Hou YJ; Zhang L; Li Y
    J Integr Med; 2022 Jan; 20(1):13-25. PubMed ID: 34838459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-Life Experience of Biologic Treatment for Asthma on Chronic Rhinosinusitis: A Finnish Cohort.
    Lyly A; Genberg E; Kauppi P; Virkkula P; Lee SE; Laidlaw TM; Toppila-Salmi S; Lundberg M
    Int Arch Allergy Immunol; 2023; 184(2):149-160. PubMed ID: 36349770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps.
    Koski RR; Hill L; Taavola K
    J Pharm Technol; 2022 Oct; 38(5):289-296. PubMed ID: 36046351
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of Serum Total Immunoglobulin E, Interleukin-17 and Pentraxin-3 as Biomarkers for Chronic Rhinosinusitis With Nasal Polyposis.
    Hussien HA; Habieb MS; Hamdan AM
    Am J Rhinol Allergy; 2021 Sep; 35(5):640-646. PubMed ID: 33356412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
    De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
    Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis.
    Banglawala SM; Oyer SL; Lohia S; Psaltis AJ; Soler ZM; Schlosser RJ
    Int Forum Allergy Rhinol; 2014 Dec; 4(12):986-94. PubMed ID: 25400017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.